With my research, me and my team work very hard to support the implementation of the 3Rs principle (Refine, Replace and Reduce) in animal testing, and promote the European Commission vision of a sustainable pharmaceutical research and drug development animal testing free within 2030. My research is based on a unique combination of in vitro and computational (in silico) methods to predict the behaviour of new drugs and drug formulations in vivo to serve biowaiver in drug discovery and pre-clinical stage of drug development. All my projects include collaboration with pharmaceutical industries and pharmaceutical stakeholders.
My ambition as researcher is to to contribute to the United Nations Sustainable Development Goals (SDGs) as follows:
Better understanding of drug absorption mechanism empowers new and potent medicine, for the health and well-being for all |
|
Technologies that replace animal testing and utilize little water help to ensure availability and sustainable management of water supply for all |
|
The implementation of recyclable In vitro/in silico tools in pharmaceutics R&D promotes a sustainable industrialization |
|
A cost-effective drug development free from animal testing means affordable drugs to everyone, reducing inequality within and among countries |
|
Refining, Reducing and Replacing animal testing reduces the energy consumption and CO2 emissions from pharmaceutical industries, positively affecting climate changes |
|
We collaborate with industrial and academic partners that share our very same sustainable vision |
Please have a look at this video that describes how I see the future pharmaceutical development. Vision I share with my industrial partner Phabioc GmbH.